These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8125617

  • 1. Assessment of acute parathyroid responsiveness to high calcium dialysate in uremic patients.
    Melan A, Schiffl H, Held E, Horn K.
    Int J Artif Organs; 1993 Oct; 16(10):711-5. PubMed ID: 8125617
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R, Romanini D, Bacchella L, Nai M, Aprile C, Santagostino M, De Vincenzi A.
    Nephron; 1991 Oct; 57(3):273-82. PubMed ID: 2017266
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
    Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Scolari F, Cancarini GC, Maiorca R.
    Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
    [Abstract] [Full Text] [Related]

  • 5. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
    Saha H, Pietilä K, Mustonen J, Pasternack A, Mörsky P.
    Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
    [Abstract] [Full Text] [Related]

  • 6. Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies.
    Muirhead N, Catto GR, Edward N, Adami S, Manning RM, O'Riordan JL.
    Br Med J (Clin Res Ed); 1984 Jan 21; 288(6412):177-9. PubMed ID: 6419845
    [Abstract] [Full Text] [Related]

  • 7. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F, Corradi B, Cosci P, Colecchia M, Leopardi O, Grossi L, Oldini C, Imbasciati E.
    Nephrol Dial Transplant; 1996 Jan 21; 11(1):81-7. PubMed ID: 8649657
    [Abstract] [Full Text] [Related]

  • 8. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH, Roy L, Lepage R, Gascon-Barré M, D'Amour P.
    Miner Electrolyte Metab; 1997 Jan 21; 23(1):25-32. PubMed ID: 9058366
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr 21; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
    Fernández E, Borràs M, Pais B, Montoliu J.
    J Am Soc Nephrol; 1995 Jul 21; 6(1):132-5. PubMed ID: 7579066
    [Abstract] [Full Text] [Related]

  • 13. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
    J Nephrol; 2003 Jul 21; 16(5):716-20. PubMed ID: 14733419
    [Abstract] [Full Text] [Related]

  • 14. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
    Gonzalez-Parra E, Gonzalez-Casaus ML, Arenas MD, Sainz-Prestel V, Gonzalez-Espinoza L, Muñoz-Rodriguez MA, Tabikh A, Egido J, Ortiz A.
    Blood Purif; 2014 Jul 21; 38(3-4):224-33. PubMed ID: 25531119
    [Abstract] [Full Text] [Related]

  • 15. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Jul 21; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 16. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E, De Grandi R, Augeri C, Claudiani F, Di Maio G.
    Kidney Int; 1994 Oct 21; 46(4):1124-32. PubMed ID: 7861707
    [Abstract] [Full Text] [Related]

  • 17. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep 21; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 18. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
    Ando R, Naito S, Inagaki Y, Hata T, Ishida Y, Chida Y, Takayama M, Tachibana K, Ohtsuka M, Inoue A.
    Ther Apher Dial; 2005 Feb 21; 9(1):16-23. PubMed ID: 15828901
    [Abstract] [Full Text] [Related]

  • 19. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Feb 21; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 20. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S, Wazny LD, Martin JE.
    Can J Clin Pharmacol; 2008 Feb 21; 15(1):e36-43. PubMed ID: 18192704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.